Specialty Chemicals Startup Scimplify $40 million in Financing

   Scimplify Received US $40 million Round B Financing to Reconstruct Global Supply Chain of Specialty Chemicals (Full Text Introduction: Science and Technology Enterprises Scimplify Completed US $40 million Round B Financing, Raised US $54 million Accumulatively, Covering 16 Countries Markets Through "Scientific Research + Manufacturing" Platform, Solving the Problem of Mismatch between Production Capacity and Demand in Specialty Chemicals Industry.)

   specialty chemicals industry ushers in digital transformation pioneer. Scimplify recently announced the completion of the B round of financing jointly led by Accel and Bertelsmann India Investment Fund, raising a total of US $40 million, with the cumulative financing scale climbing to US $54 million. The capital injection will accelerate the construction of its global manufacturing network and promote the intelligent upgrading of the supply chain in the three core areas of life science and agricultural science and technology.

    this round of financing brings together multiple resources: in addition to the lead investors Accel, Bertelsmann India, UMI Capital and existing investors Omnivore, 3one4 Capital continue to increase. According to the data, the company received a total of US $13.5 million in seed round and round A financing, and the scale of this round of financing has tripled. The funds will focus on expanding the R & D center in Munich, Germany, expanding the North American operation hub, and deepening the layout in emerging fields such as new energy materials.

    "There are structural contradictions in the traditional specialty chemicals industry-30% of the global production capacity is idle and 20% of the customized demand gap coexists. Co-founder Sachin Santhosh to explain his business model breakthrough: integrating more than 300 professional factories and 2000 scientific researchers around the world through a digital platform to build a flexible manufacturing network. The system can dynamically allocate production capacity according to market demand, reducing the research and development cycle by 60% and increasing the order delivery efficiency by 75%. At present, the platform has served customers in 16 countries, including the United States, Japan and Europe, and has an advantage in market segments such as pharmaceutical intermediates and environmentally friendly agrochemicals.

    "Geopolitical volatility has led to a revolution in supply chain flexibility, and the Scimplify R & D-led model is reshaping the rules of the industry," said Rachit Parekh, partner at Accel,
, a strategic perspective for investors. "Bertelsmann India partner Rohit Sood added that the company's Hyderabad R & D center has obtained 12 patented technologies, supporting its export scale to achieve a compound annual growth rate of 180 percent. It is worth noting that Scimplify original "demand-capacity" intelligent matching algorithm can increase equipment utilization from the industry average of 38% to 82%.

    According to the disclosed three-year plan Future Industry Map of enterprises will invest US $20 million to develop AI-driven molecular simulation systems, with the goal of reducing the cost of new product research and development by 40%. At the same time, the "Global Manufacturing Node Program" will be launched, and five new regional hubs will be added by 2025 to achieve a processing capacity of 500000 metric tons/year of specialty chemicals. These initiatives mark the transformation of Scimplify from a supply chain optimizer to an industrial technology standard setter, and the flexible manufacturing ecology it builds may become a key infrastructure for the global chemical 4.0 revolution.